NEW YORK (GenomeWeb) – Computational biology startup Camp4 Therapeutics has emerged from stealth mode and closed on a $30 million Series A round of venture capital.

Andreessen Horowitz led the round, with participation from Polaris Partners and the Kraft Group. Polaris Partners supported an earlier seed round, according to Cambridge, Massachusetts-based Camp4.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.